Optinose is a specialty pharmaceutical company focused on creating and bringing to market innovative products for patients with diseases treated by ear, nose, and throat (ENT) and allergy specialists. Our mission is to improve the quality of life for patients. We are working to accomplish that by becoming the leading specialty healthcare company dedicated to creating innovative products that become standard of care for diseases cared for directly by, or in consultation with, ENT and allergy specialists. Our first product for these patients uses one of our patented Bi-Directional⢠Exhalation Delivery Systems (EDS) to uniquely deliver a potent steroid deep into the nose where inflammation can be hard to reach. Our EDS technology has other applications, such as in treatment of neurological or psychiatric disorders. Although these areas are not our focus, we have already successfully developed and out-licensed one product in that space, and plan to partner with organizations who focus on central nervous system treatments to develop more. Source
No articles found.
NextCure is a clinical-stage biopharmaceutical company committed to discovering an...
NextCure is a clinical-stage biopharmaceutical ...
Health Catalyst is a leading provider of data and analytics technology and service...
Health Catalyst is a leading provider of data a...
Global leader in therapeutic ultrasound and present in the market for more than 35...
Global leader in therapeutic ultrasound and pre...
Portola Pharmaceuticals is a global, commercial-stage biopharmaceutical company fo...
Portola Pharmaceuticals is a global, commercial...
Dynavax Technologies Corporation (Nasdaq: DVAX) is a clinical-stage biopharmaceuti...
Dynavax Technologies Corporation (Nasdaq: DVAX)...
Sanofi is dedicated to supporting people through their health challenges. We are a...
Sanofi is dedicated to supporting people throug...
U.S. Well Services, LLC, provides high-pressure, hydraulic fracturing services in ...
U.S. Well Services, LLC, provides high-pressure...
Join the National Investor Network and get the latest information with your interests in mind.